Human Oncology & Pathogenesis Program

The David Solit Lab

Research

David Solit
David B. Solit, MD
Co-Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology

Our research is based on the underlying hypothesis that the ability to inhibit an oncogenic pathway and block cancer growth will vary based on cell lineage and the complement of mutations within the tumor. To design rational therapeutic studies, we must define not only the spectrum of genetic changes within particular tumor types but also the mechanisms by which these alterations support tumor growth, survival, metastasis, and other hallmarks of cancer.

View Lab Overview

Research Projects

The David Solit Lab

Publications Highlights

View All Publications

People

David Solit

David B. Solit, MD

Co-Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology

  • Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.
  • MD, University of Pennsylvania
solitd@mskcc.org
Email Address
View physician profile
Physician profile

Members

Alexis M. Jones, MS
Research Lab Manager
Aphrothiti Hanrahan, PhD
Assistant Lab Member
Gopa Iyer, MD
Assistant Attending, Genitourinary Oncology Service
Kwanghee Kim
Associate Attending Biologist
Sizhi Gao
Scientific Research Lead
GSK Graduate Student
Weill Cornell BCMB Graduate Student
Weill Cornell Graduate Student
Computational Biologist I
Hikmat A. Al-Ahmadie, MD
Associate Attending Pathologist, Memorial Hospital
Senior Research Scientist
Senior Research Scientist
Hui Jiang
Research Associate
Scientific Research Lead
Medical Student
Assistant Attending Pathologist
Aaron Gillmor
Computational Biologist
Olvania-Danyca Hilaire
Senior Research Technician
Bioinformatics Software Engineer
Graduate Research Assistant
Research Technician
Alejandra Lopez Rojas
Research Technician
Chione Sylvester
Administrative Assistant
GSK Graduate Student
Ao Zhang
Urologic Oncology Fellow
Shweta Chavan
Senior Computational Biologist
Helen Won, MS
Senior Computational Biologist
Research Technician
Wenhuo Hu, PhD
Research Associate
Research Fellow
Program Assistant
Research Fellow
Senior Research Technician
Naresh Vasani
Research Assistant
Urology Fellow
Tripti Shrestha Bhattarai, PhD
Research Associate
Senior Research Scientist
Visiting Investigator
Urology Fellow
Visiting Investigator
Florestan Koll
Visiting Investigator
Research Fellow
Research Technician
Kate Weiss
Research Technician
Research Technician
Mark Donoghue, PhD
Associate Director, CMO
Medical Student
Research Technician
Bioinformatics Software Engineer
Allison Richards, Computational Biologist II
Lead, CCS Analyst
Anne Marie Noronha
Bioinformatics Software Engineer
Urology Fellow
Hyung Jun Woo
Senior Computational Biologist
Martina Bradic
Senior Computational Biologist
Samuel Tischfield
Senior Computational Biologist
Vasilisa Rudneva
Senior Computational Biologist
Senior Computational Biologist
Yixiao Gong
Lead, TEMPO Pipeline
Julian Agin-Liebes
Research Technician
Research Technician
François Audenet
Urologic Oncology Fellow
Aditya Bagrodia
Urology Fellow
David Barron, MD, PhD
Radiation Oncology Resident
Federica Catalanotti, PhD
Research Fellow
Eugene K. Cha, MD
Assistant Attending, Urologic Oncology
Shawn Dason, Urologic Oncology Fellow
Urologic Oncology Fellow
Neil Desai, MD, MHS
Resident in Radiation Oncology
Noah Friedman, Computational Biologist II
Computational Biologist
Senior Technician
Joseph Hreiki, MD
Research Fellow
Sumit  Isharwal
Urologic Oncology Fellow
Manickam Janakiraman, PhD
Research Associate
Philip Kim, MD
Clinical Research Fellow
Urology Fellow
Qiang Li
Urology Fellow
Urology Fellow
Moriah Heller Nissan, PhD
OncoKB Scientist, Memorial Sloan Kettering Cancer Center, New York, NY
Computational Biologist
Ricardo Ramirez
Cornell University Graduate Student
John Sfakianos
Urology Fellow
Tara Soumerai
Assistant Attending, Gynecologic Medical Oncology Service
Brooke Sylvester, PhD
Research Fellow
Efsevia Vakiani, MD, PhD
Assistant Attending Pathologist
Hannah Wise
Manager, Clinical Data at Flatiron Health, New York, NY
Feng Xing, PhD
Research Fellow
Alyssa Yee
Medical Student
Graduate Research Assistant
Li Kong, PhD
Research Fellow
Yogindra Persaud
Research Technician

Achievements

  • Member, American Society for Clinical Investigation (2011)
  • Louise and Allston Boyer Young Investigator Award for Basic Research, Memorial Sloan Kettering Cancer Center (2007)
  • Kimmel Scholar, Sidney Kimmel Foundation for Cancer Research (2007)
  • Career Development Award, American Society of Clinical Oncology (2002)
  • Young Investigator Award, American Society of Clinical (2001)
  • Doris Duke Translational Award, Doris Duke Foundation (2001)
  • Clinical Scholars Research Fellow, National Institutes of Health (2000)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Career Opportunities

Apply now

Postdoc Position in Preclinical and Translational Cancer Genomics and Therapeutics

Apply now

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

David B. Solit discloses the following relationships and financial interests:

  • Antares Therapeutics, Inc.
    Equity
  • BridgeBio Inc.
    Professional Services and Activities
  • Corramedical, Inc.
    Equity
  • Elsie Biotechnologies, Inc.
    Equity; Professional Services and Activities
  • Fog Pharmaceuticals, Inc.
    Professional Services and Activities
  • Fore Biotherapeutics
    Equity; Professional Services and Activities
  • Function Oncology, Inc.
    Equity; Professional Services and Activities
  • Meliora Therapeutics
    Professional Services and Activities
  • Paige.AI, Inc.
    Professional Services and Activities
  • Pfizer, Inc.
    Professional Services and Activities
  • Pyramid Biosciences, Inc.
    Equity; Professional Services and Activities
  • Scorpion Therapeutics, Inc.
    Equity; Professional Services and Activities

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures